4//SEC Filing
O'Neill Vincent 4
Accession 0001104659-25-030688
CIK 0001720893other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 6:08 PM ET
Size
6.1 KB
Accession
0001104659-25-030688
Insider Transaction Report
Form 4
O'Neill Vincent
Other
Transactions
- Award
Stock Option (right to buy)
2024-07-22+1,875→ 1,875 totalExercise: $1.20Exp: 2034-07-22→ Common Stock (1,875 underlying)
Footnotes (2)
- [F1]The share amount has been adjusted to reflect the reverse stock split effective on February 7, 2025 whereby every sixteen shares issued and outstanding prior to the split were combined and converted into one share of common stock.
- [F2]The Reporting Person was granted an option to purchase 1,875 shares of common stock, which vests as to 50% on each of the first and second anniversaries of the grant date, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Due to the Reporting Person's termination of employment, the unvested Stock Option was forfeited.
Documents
Issuer
BioXcel Therapeutics, Inc.
CIK 0001720893
Entity typeother
Related Parties
1- filerCIK 0001672718
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 6:08 PM ET
- Size
- 6.1 KB